The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

NCT00990808 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: anacetrapib
DRUG: Comparator: atorvastatin
DRUG: Comparator: placebo to MK0859
DRUG: Comparator: placebo to atorvastatin

Sponsor

Merck Sharp & Dohme LLC